The American Diabetes Association’s (ADA’s) Chief Scientific, Medical and Mission Officer, William T. Cefalu, MD, JDRF Chief Mission Officer, Aaron Kowlaski and other prominent diabetes advocates testified before the U.S. House of Representatives Committee on Energy & Commerce’s Oversight and Investigations Subcommittee today. The topic, “Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Prices” addressed the rising costs of insulin, which impact millions of Americans with diabetes who rely on this life-sustaining medication. Watch the hearings here.
